Search
for
Sort by
Research 841–870 of 1000+
- The role of nuclear hormone receptors in cutaneous wound repair
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris
- Hair Loss Pattern due to Chemotherapy-Induced Anagen Effluvium: A Cross-Sectional Observation
- Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Sulfatase inhibitors: a patent review
- Hormonal treatment of acne vulgaris: an update
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands
- Female type of adult acne: Physiological and psychological considerations and management
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Polycystic ovary syndrome: A review for dermatologists
- Adolescent hair loss
- Cardiometabolic profile of young women with hypoprolactinemia
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
- Congenital adrenal hyperplasia
- Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- The Hirsute Woman: Challenges in Evaluation and Management
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates